Video Experimental Relacionado
Updated: Jan 7, 2026
10:37
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
15.4K
Investigación sobre el Cuidado de la Demencia y Factores Psicosociales
Sarah Pakzad1, Paul Bourque2, Daniel Saucier1
1Université de Moncton, Moncton, NB, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
Resumen
Los farmacéuticos están probando una herramienta digital de evaluación cognitiva para mejorar la detección temprana de la demencia y el cuidado. Este estudio explora cómo el Índice de Fragilidad Neurocognitiva (NFI) ayuda a los farmacéuticos en el manejo de la salud cognitiva en adultos mayores de 50 años.
Área de la Ciencia:
- Gerontología
- Ciencias Cognitivas
- Atención Farmacéutica
Sus antecedentes:
- Los farmacéuticos desempeñan un papel clave en la atención primaria canadiense.
- La integración de la tecnología en la evaluación cognitiva puede ayudar en el cuidado de la demencia.
- El Índice de Fragilidad Neurocognitiva (NFI) es una herramienta digital para la evaluación cognitiva.
Objetivo del estudio:
- Examinar cómo el uso del NFI digital por parte de los farmacéuticos puede mejorar la identificación temprana de trastornos cognitivos.
- Evaluar la contribución del NFI a la calidad del tratamiento y la atención de pacientes con quejas cognitivas.
- Evaluar la pertinencia del NFI en el seguimiento del deterioro cognitivo a lo largo del tiempo.
Principales métodos:
- Se invitó a participar a farmacias de New Brunswick.
- Los farmacéuticos recibieron capacitación sobre la administración de la herramienta de evaluación NFI.
- El estudio implica evaluaciones repetidas cada 3-12 meses para clientes de 50 años o más.
- Los análisis longitudinales rastrearán el deterioro cognitivo y las intervenciones farmacéuticas.
Principales resultados:
- Nueve farmacéuticos han sido reclutados y capacitados.
- Las evaluaciones iniciales comenzaron en noviembre de 2024 con 12 participantes.
- Los farmacéuticos brindaron seguimiento, incluida la programación, las derivaciones y la revisión de medicamentos.
Conclusiones:
- El reclutamiento y la capacitación de farmacéuticos están en curso.
- Los farmacéuticos activos muestran un interés continuo en usar el NFI.
- Los resultados informarán el impacto del NFI en el manejo del deterioro cognitivo en personas mayores de 50 años.
Palabras clave:
Atención farmacéuticaDemenciaEvaluación cognitivaÍndice de Fragilidad NeurocognitivaAtención primariaMás Videos Relacionados
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
Videos de Conceptos Relacionados
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K